Article

Felix Frueh, PhD, Speaks about the Health Economics of Personalized Medicine

In this video, Felix Frueh, PhD, President, Medco Research, discusses the advancements in personalized medicine over the past decade. Dr. Frueh also speaks about the clinical data that are being generated in order to prove to payers that this area of medicine is not only valuable but also affordable.

In this video, Felix Frueh, PhD, President, Medco Research, discusses the advancements in personalized medicine over the past decade. Dr. Frueh also speaks about the clinical data that are being generated in order to prove to payers that this area of medicine is not only valuable but also affordable.

This video was taken at CBI's 4th Annual Forum for Payers on Personalized Medicine conference in Washington, DC, on March 13, 2012.

Related Videos
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Io Hui, PhD, researcher at The University of Edinburgh
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
Adam Colborn, JD, of AMCP
Corey McEwen, PharmD, MS
Daniel Howell, MBBS
Jonathan Kurman, MD
Tetyana Kendzerska, MD
Krunal Patel, MD
Scott Manaker,MD
Related Content
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
October 10th 2024

Advancing Breast Cancer Care With HER2-Targeted Therapies

Maggie L. Shaw
In this interview from our Institute for Value-Based Medicine® event in Boston, we speak with Michael Hassett, MD, MPH, Dana-Farber Cancer Institute, on the clinical significance and cost implications of HER2 in the breast cancer space.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024

Sustaining Compassionate Trauma Care Across Communities

Maggie L. Shaw
September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Surbhi Sidana, MD
October 3rd 2024

What the Approval of Isatuximab Plus VRd Adds to Multiple Myeloma Care

Hayden E. Klein Maggie L. Shaw
Surbhi Sidana, MD, MBBS, shares how the addition of an anti-CD38 antibody to the VRd regimen significantly improves progression-free survival for patients with transplant-ineligible multiple myeloma.
Managed Care Cast
September 27th 2024

Frameworks for Advancing Health Equity: Community Wellness Centers

Giuliana Grossi
Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Q&A With Varsha Srivatsan, MSci, O’Neill Institute for National and Global Health Law
October 2nd 2024

From Criminalization to Compassion: The Evolution of HIV Laws

Maggie L. Shaw
The 25th International AIDS Conference took place July 22-26 in Munich, Germany, and one of the sessions delved into the potential impact of civil society laws on the 95-95-95 targets as laid out in the UNAIDS Global AIDS Strategy for 2021 to 2026.
JT Lew, PharmD, MBA
October 1st 2024

Achieving the Goals of Value-Based Care for Multiple Sclerosis

Skylar Jeremias
Value-based agreements come with risks and benefits, but a health system’s existing facilities and initiatives can help support the goals associated with them, JT Lew, PharmD, MBA, a managed care pharmacist at MultiCare Health System, explained.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo